Aastrom Biosciences announced that the company's board has named Dan Orlando interim CEO of Aastrom. Orlando, who joined Aastrom as Chief Commercial Officer in August, will assume the position of interim CEO effective December 14, 2012. Aastrom's president and CEO Tim Mayleben is retiring but will remain an active member of the company's board. Mayleben will continue to support the transition to a permanent CEO at the company for which a search is ongoing.
As traders wait on the Federal Reserve, putting off any major decisions until they hear the latest word in FOMC …